465 related articles for article (PubMed ID: 29389748)
1. Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Anagnostou E
Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Naguy A
J Nerv Ment Dis; 2017 Sep; 205(9):738. PubMed ID: 28846573
[No Abstract] [Full Text] [Related]
3. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
5. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
Howes OD; Rogdaki M; Findon JL; Wichers RH; Charman T; King BH; Loth E; McAlonan GM; McCracken JT; Parr JR; Povey C; Santosh P; Wallace S; Simonoff E; Murphy DG
J Psychopharmacol; 2018 Jan; 32(1):3-29. PubMed ID: 29237331
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.
Lamy M; Pedapati EV; Dominick KL; Wink LK; Erickson CA
Paediatr Drugs; 2020 Oct; 22(5):473-483. PubMed ID: 32686015
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
8. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
[TBL] [Abstract][Full Text] [Related]
9. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole for treating irritability associated with autism spectrum disorders.
Bartram LA; Lozano J; Coury DL
Expert Opin Pharmacother; 2019 Aug; 20(12):1421-1427. PubMed ID: 31180743
[No Abstract] [Full Text] [Related]
11. Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.
Patel BD; Barzman DH
Psychiatr Q; 2013 Dec; 84(4):407-15. PubMed ID: 23443759
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
Madden JM; Lakoma MD; Lynch FL; Rusinak D; Owen-Smith AA; Coleman KJ; Quinn VP; Yau VM; Qian YX; Croen LA
J Autism Dev Disord; 2017 Jan; 47(1):144-154. PubMed ID: 27817163
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
14. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotics for behavioral problems in children.
Shafiq S; Pringsheim T
Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate an effective treatment for ADHD?
McDougle CJ
J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
[No Abstract] [Full Text] [Related]
17. Not just another antipsychotic-for-conduct-problems trial.
Blader JC
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
[No Abstract] [Full Text] [Related]
18. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
[TBL] [Abstract][Full Text] [Related]
19. [Autism and attention deficit hyperactivity disorder: pharmacological intervention].
Fernández-Jaén A; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
Rev Neurol; 2013 Sep; 57 Suppl 1():S205-10. PubMed ID: 23897149
[TBL] [Abstract][Full Text] [Related]
20. No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder.
Harfterkamp M; van der Meer D; van der Loo-Neus G; Buitelaar JK; Minderaa RB; Hoekstra PJ
J Child Adolesc Psychopharmacol; 2015 May; 25(4):372-5. PubMed ID: 25919900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
